Salute e Benessere

Tsingke Shines at Cell & Gene Therapy International 2024

At the exhibition, we had in-depth conversations with several industry decision-makers about cell and gene therapy and how Tsingke can further support scientists in making breakthroughs. Many of our customers are impressed with our self-developed synthetic materials, consumables, bioreagents, and equipment, and appreciate the quality and speed of our customized gene synthesis, oligomer synthesis, and virus packaging services. We are particularly excited about the prospects of collaboration…
PR Newswire
14/10/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 14 October 2024– On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024.Under the...
Nasdaq GlobeNewswire
14/10/2024

Canton Fair Launches New Mobile App to Enhance Attendee Experience Ahead of…

The 136th Canton Fair, set to open on October 15, is designed to serve as a comprehensive one-stop trade platform for global buyers. It will feature an extensive range of high-quality, cost-effective, and reliable products. The fair is organized into three distinct phases, each dedicated to a specific theme: The 136th Canton Fair, set to open onOctober 15, is designed to serve as a comprehensive one-stop trade platform for global buyers. It will feature an extensive range of high-quality,...
PR Newswire
14/10/2024

Smartee Presents Mandibular Repositioning Therapy in Valencia

Local expert Prof. Vicente M. Torres Celda summarized Prof. Shen's presentation and shared his positive experiences with Smartee. Additionally, Dr. María del Carmen Pérez Cabrilla, the top user of GS in Spain, presented her GS cases and expressed her satisfaction with Smartee's services. Local expert Prof.Vicente M. Torres Celdasummarized Prof. Shen's presentation and shared his positive experiences with Smartee. Additionally, Dr. María del Carmen Pérez Cabrilla, the top user of GS in...
PR Newswire
14/10/2024

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced…

The FDA-approved Somerset facility employs approximately 200 skilled scientists and technicians and is a Center of Excellence for advanced delivery of oral dosage forms, complementing Ardena's existing oral solid expertise. This acquisition also positions Ardena well to expand its bioanalytical services in the US to serve a growing client base driven by an ever-increasing demand for advanced drug development services. The facility's specialized technologies and analytical capabilities...
Nasdaq GlobeNewswire
14/10/2024

Buyback of Class B shares in Essity during week 41, 2024

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All purchases...
PR Newswire
14/10/2024

Chiesi Group's new Biotech Center of Excellence brings the future of medicine to…

This adaptability ensures Chiesi will remain at the forefront of medical trends, while the Center's capability will support the production of small and large batches, and both experimental and approved drugs to facilitate a seamless transition from clinical trials to commercial manufacturing. The new center will enhance Chiesi's focus areas in respiratory, special care treatments, and rare diseases, thereby strengthening its overall strategic position. This adaptability ensures Chiesi will...
PR Newswire
14/10/2024

JULIEN'S AUCTIONS ANNOUNCES "UNDER DURESS: THE BANKSY ARCHIVE OF STEVE LAZARIDES…

This extraordinary archive features some of Banksy's most famous visual artworks, including "Drill Rat," "Antenna Chimpanzee Head," "Laugh Now," "Bomb Hugger," "Love Is In The Air (aka Flower Thrower)," and "Girl With Balloon (aka Balloon Girl)," alongside rare and personal items such as Banksy's worn Puma "Turf War" sneakers, his original erotic art concept sketches, and a set of 15 burner phones used to communicate with…
PR Newswire
14/10/2024

Orion's collaboration partner Bayer submits application for third indication of…

ORION CORPORATIONINVESTOR NEWS14 OCTOBER 2024 at 11.00 EEST Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion's collaboration partner Bayer today announced the submission of an application to the European Medicines Agency (EMA) for the oral androgen receptor inhibitor (ARi) darolutamide. Bayer is seeking approval for the use of darolutamide in combination with androgen deprivation therapy (ADT) in patients with...
Nasdaq GlobeNewswire
14/10/2024

Modern Meadow Appoints David Williamson as CEO

NUTLEY, N.J., Oct. 14, 2024 /PRNewswire/ -- Modern Meadow, a leader in sustainable materials, has announced that David Williamson, PhD, will transition from president and chief operating officer (COO) to chief executive officer (CEO), effective October 14, 2024. Dr. Williamson has served in multiple roles within the company since 2015 and will now spearhead its next phase of growth. As CEO, Dr. Williamson will continue executing on the company's strategic growth plan to create sustainable…
PR Newswire
14/10/2024

Inventiva announces Filing of 2024 Half-Year Report – Conditions for Accessing…

Daix (France), Long Island City (New York, United States), October 14, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“ MASH ”), also known as non-alcoholic steatohepatitis (“ NASH ”), and other diseases with significant unmet medical needs, today announced the filing, for the...
Nasdaq GlobeNewswire
14/10/2024

Inventiva announces financing of up to €348 million to advance the NATiV3 Phase…

Inventiva secures €94.1 million of a multi-tranche equity financing of up to €348 million, subject to satisfaction of specified conditions, from both new and existing investors, and up to $30 million in milestone payments relating to equity financing pursuant to amendment to license and collaboration agreement with CTTQ.Proceeds from financing to be primarily used to advance Inventiva's Phase 3, NATiV3 clinical trial evaluating lanifibranor in patients with MASH. More than 1,100 patients...
Nasdaq GlobeNewswire
14/10/2024

Nomination Committee appointed for SciBase Holding's Annual General Meeting in…

The appointments have been made in accordance with the instructions regarding principles for the appointment of the company nominating committee which were determined at the Annual General Meeting of SciBase Holding on June 13, 2024. The appointments have been made in accordance with the instructions regarding principles for the appointment of the company nominating committee which were determined at the Annual General Meeting of SciBase Holding onJune 13, 2024. The Annual General Meeting...
PR Newswire
14/10/2024

Discover Medtecs' Latest Innovations in Medical Protection and Sustainability at…

Medtecs has made significant strides in promoting sustainability by using biodegradable materials for accessories such as shoe covers and bouffant caps, while also adopting automation technologies that enhance production efficiency and product quality. Key innovations include automated systems such as a fabric inspection system, flatbed cutter, mold machine, and pocket stitching machine. By reducing reliance on manual labor and standardizing production, Medtecs is improving its capacity and…
PR Newswire
14/10/2024

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing

Press Release Nicox and Soleus Sign $16.5 million Royalty and Equity FinancingGross proceeds of $15 million (€13.7 million) for the sale of Nicox's net share of the VYZULTA royalty to SoleusSoleus investing $1.5 million (€1.37 million) in Nicox shares, issued at €0.3144 per share, representing a 20% premium to the closing price on October 11, 2024, with attached warrants valued at $0.75 million (€0.69 million) at an exercise price of €0.5240 per share, representing a 100% premium to...
Nasdaq GlobeNewswire
14/10/2024

Embark on a Journey of Holistic Wellbeing at Banyan Tree Dubai's Brand-New Spa

Upon entering the spa, guests can engage with nature through features such as the Tranquility Garden and barefoot pathways, allowing you to feel truly connected and unlock a sense of groundedness. One of the spa's standout features is the Rainforest experience, a multisensory journey comprising a rain walk with ceiling and wall spa water jets, steam and sauna rooms, and a variety of invigorating shower experiences. Upon entering the spa, guests can engage with nature through features such as...
PR Newswire
14/10/2024

Majority of children with spinal muscular atrophy (SMA) treated with Roche's…

Positive data confirm Evrysdi efficacy and safety in children first treated pre-symptomatically before six weeks of age, with most achieving motor milestones similar to children without SMAAll children were able to swallow and feed orally, with none requiring permanent ventilationEvrysdi is the only non-invasive SMA therapy and is approved in over 100 countries, with more than 16,000 people with SMA treated globallyBasel, 14 October 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY)...
Nasdaq GlobeNewswire
14/10/2024

Novotech Awarded Frost & Sullivan's 2024 Global Company of the Year Award for…

Novotech enables biotech companies to navigate the complex global regulatory landscape by leveraging its extensive expertise in local regulations and deep understanding of cultural nuances. With 34 office locations across the United States, Europe, and the Asia-Pacific region—including Australia, China, India, Malaysia, New Zealand, and Thailand—Novotech's global presence ensures that biotech firms receive tailored solutions that meet their unique needs. Additionally, Novotech distinguishes…
PR Newswire
14/10/2024

UEG Week: Novel procedure combined with semaglutide may eliminate insulin…

Globally, T2D affects 422 million people, with obesity recognised as a significant risk factor. While insulin therapy is commonly used to manage blood sugar levels in T2D patients, it can result in side effects such as weight gain and further complicate diabetes management. A need therefore exists for alternative treatment strategies. Globally, T2D affects 422 million people, with obesity recognised as a significant risk factor. While insulin therapy is commonly used to manage blood sugar...
PR Newswire
14/10/2024

90th CMEF in Shenzhen Showcases Global MedTech Innovations and Insights

A notable feature of this year's exhibition is a strategic agreement. In June 2025, RSE will host THE HEALTH INDUSTRY SERIES – ASEAN (tHIS ASEAN) co-located with APHM. The Southeast Asian healthcare market is set for rapid expansion, with an expected annual growth rate of 10-12%. This partnership seeks to unite healthcare professionals and industry leaders in Southeast Asia, encouraging cooperation and progress to improve global health standards. A notable feature of this year's exhibition is…
PR Newswire
13/10/2024

SkylineDx Announces Data from Largest Prospective Multi-Center Melanoma Gene…

The trial, conducted at nine academic sites in the United States has been successfully led by three principal investigators Dr. V. Sondak M.D., Chair of the Department of Cutaneous Oncology at Moffitt Cancer Center, Dr. T. Hieken, M.D., Surgical Oncologist and Professor of Surgery, Mayo Clinic, and Dr. M. Egger M.D., M.P.H., Associate Professor, Surgical Oncologist UofL Health Brown Cancer Center Louisville. The trial validated the predictive power of the CP-GEP (Clinical-Pathologic and Gene…
PR Newswire
13/10/2024

World Thrombosis Day raises global awareness of blood clot dangers through…

The campaign has partnered with more than 6,000 organizations worldwide to implement impactful initiatives. This year, World Thrombosis Day emphasizes the impact on women's health with the launch of a new global survey aimed at understanding women's awareness of their health risks. The campaign has partnered with more than 6,000 organizations worldwide to implement impactful initiatives. This year, World Thrombosis Day emphasizes the impact on women's health with the launch of a new global...
PR Newswire
13/10/2024

BioVaxys Announces Marketing Program

As consideration for the Services, the Company will pay OTB a cash fee in advance in the amount of $130,000. The Company will not issue any securities to OTB as compensation for the Services. Pursuant to the terms of the Agreement, OTB will provide the Services in order to communicate information about the Company, including, but not limited to: As consideration for the Services, the Company will pay OTB a cash fee in advance in the amount of$130,000. The Company will not issue any...
PR Newswire
11/10/2024

Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, Oct.11, 2024(GLOBE NEWSWIRE) --Paris, France, October 11, 2024Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDate Number of Shares OutstandingTotal number of...
Nasdaq GlobeNewswire
11/10/2024
Altri  Comunicati